bioRxiv / medRxivopen access
Development of gemcitabine-modified miR-15a as a novel, multimodal treatment strategy to overcome 5-FU and oxaliplatin resistance in colorectal cancer
cancer biology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 234313
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.